Coloplast A/S (ADR)
General ticker "CLPBY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $22.8B (TTM average)
Coloplast A/S (ADR) does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 0.8%: low 8.47$, high 8.60$
Factors to consider:
- Earnings expected soon, date: 2026-02-03 bmo
- Company pays dividends (semi-annually): last record date 2025-12-08, amount 0.18$ (Y4.26%)
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [7.35$, 11.68$]
- 2026-09-30 to 2027-09-30 estimated range: [8.41$, 12.90$]
Financial Metrics affecting the CLPBY estimates:
- Positive: with PPE of 34.5 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 27.19 > 18.34
- Negative: Industry operating cash flow per share per price (median), % of 1.00 <= 5.48
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -5.72 <= 2.99
- Negative: Industry inventory ratio change (median), % of 1.17 > 0.29
- Negative: Operating cash flow per share per price, % of 4.88 <= 6.66
Short-term CLPBY quotes
Long-term CLPBY plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | DKK24,500.00MM | DKK27,030.00MM | DKK26,254.00MM |
| Operating Expenses | DKK17,729.00MM | DKK19,710.00MM | DKK19,115.00MM |
| Operating Income | DKK6,771.00MM | DKK7,320.00MM | DKK7,139.00MM |
| Non-Operating Income | DKK-746.00MM | DKK-925.00MM | DKK-1,340.00MM |
| Interest Expense | DKK638.00MM | DKK882.00MM | DKK777.06MM |
| R&D Expense | DKK872.00MM | DKK913.00MM | DKK847.71MM |
| Income(Loss) | DKK6,025.00MM | DKK6,395.00MM | DKK5,799.00MM |
| Taxes | DKK1,242.00MM | DKK1,343.00MM | DKK2,375.00MM |
| Profit(Loss)* | DKK2,795.00MM | DKK5,052.00MM | DKK3,425.00MM |
| Stockholders Equity | DKK17,299.00MM | DKK17,942.00MM | DKK16,154.00MM |
| Inventory | DKK3,522.00MM | DKK3,672.00MM | DKK3,927.00MM |
| Assets | DKK48,159.00MM | DKK48,073.00MM | DKK48,463.00MM |
| Operating Cash Flow | DKK4,226.00MM | DKK2,766.00MM | DKK6,259.00MM |
| Capital expenditure | DKK1,241.00MM | DKK1,166.00MM | DKK1,230.00MM |
| Investing Cash Flow | DKK-8,957.00MM | DKK-1,336.00MM | DKK-1,178.00MM |
| Financing Cash Flow | DKK5,265.00MM | DKK-1,518.00MM | DKK-4,886.00MM |
| Earnings Per Share** | DKK1.30 | DKK2.25 | DKK1.52 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.